Following our successful participation in the Bridgehead program last year, to plan PGXperts’ market transition to North America, we are delighted to have been selected again this year as one of 20 scale-ups in Europe for the EIT Health Bridgehead programme.
The primary objective of this funding opportunity is to assist European digital health companies in expanding their operations beyond their domestic markets. HMG will have the chance to prepare for entry into the UK market, with the support of an accelerator.
Our renewed participation in the EIT Health programme aims to pilot PGXperts in the UK market and collect clinical data. We thank EIT Health for selecting us again and look forward to the results we will deliver by July 2024.
Read more about our funding from EIT Health here.